HealthPhoto: The HinduBharat Biotech's Nucelion to Partner with Pandorum on PRIP Ophthalmology Projects
Bharat Biotech’s subsidiary Nucelion Therapeutics and Bengaluru-based Pandorum Technologies will collaborate on two ophthalmology projects focused on advanced keratopathy and wet age-related macular degeneration. Supported by the Centre’s PRIP scheme with ₹16.97 crore funding, including ₹8 crore from PRIP, the partnership combines Pandorum’s regenerative medicine design with Nucelion’s manufacturing expertise for investigational therapies.
The Hindu··Hyderabad

